期刊
ONCOLOGY LETTERS
卷 14, 期 6, 页码 6923-6928出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2017.7092
关键词
miR-145-5p; epithelial-mesenchymal transition; mitogen-activated protein kinase kinase kinase 1; Jun N-terminal kinase 2; non-small cell lung cancer
类别
资金
- Natural Science Foundation of Guangdong Province [2016zc0160]
- Science and Technology Planning Project of Guangdong Province, China [2014A020212447]
Lung cancer is one of the most common types of tumors and the leading cause of cancer-associated mortality in the world. Additionally, non-small cell lung cancer (NSCLC) accounts for similar to 80% of all lung cancer cases. Epithelial-mesenchymal transition (EMT) is an important cell biological process, which is associated with cancer migration, metastasis, asthma and fibrosis in the lung. In the present study, it was revealed that miR-145-5p was able to suppress EMT by inactivating the c-Jun N-terminal kinase (JNK) signaling pathway in NSCLC cells. Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) was predicted and confirmed to be a novel target of miR-145-5p. Overexpression of MAP3K1 was able to reverse the inhibition of EMT induced by miR-145-5p via the JNK signaling pathway. Overall, the results revealed that miR-145-5p inhibits EMT via the JNK signaling pathway by targeting MAP3K1 in NSCLC cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据